Glycitein: A comprehensive review of its bioactivities, molecular mechanisms, and therapeutic potential

Glycitein, a distinct soy isoflavone with a unique 6‑methoxy substitution, possesses significant antioxidant capacity and ROS scavenging abilities, making it a focus in nutritional and pharmacological research.

This review synthesizes recent advancements on glycitein, covering its structural features, bioavailability modulation by glycosylation and food processing, diverse biological activities, and underlying mechanisms. It also explores strategies to enhance its therapeutic efficacy and integration into precision nutrition.

This study is a systematic review that integrates existing research on glycitein's chemical structure, physicochemical properties, bioavailability, biological activities, mechanisms of action, and potential clinical applications. It also incorporates network pharmacology and bioinformatics analyses to elucidate multi-target therapeutic effects.

The review compiles and analyzes data from various mechanistic studies and experimental models to detail glycitein's effects. These include its antioxidant properties, anti-tumor effects, anti-inflammatory actions, hepatoprotective effects, antiviral activity, antimicrobial properties, and osteoprotective effects. The review also covers its impact on cell cycle regulation, apoptosis, and various signaling pathways. Clinical applications in cardiovascular diseases, cancer, metabolic syndrome, and neurodegenerative disorders are discussed.

Glycitein exhibits significant therapeutic potential across a wide range of diseases. It demonstrates robust antioxidant, anti-tumor, anti-inflammatory, hepatoprotective, antiviral, antimicrobial, and osteoprotective effects. Its mechanisms involve scavenging ROS, modulating key signaling pathways like Nrf2-ARE, NF-κB, MAPK, and STAT3, regulating lipid metabolism, and influencing cell cycle arrest and apoptosis. Clinically, glycitein shows promise in managing cardiovascular diseases, various cancers by inhibiting proliferation, invasion, and angiogenesis, metabolic syndrome and diabetes, and neurodegenerative disorders. Its bioavailability can be enhanced through microbial fermentation and advanced extraction/purification techniques.

Glycitein is a multifaceted therapeutic agent with broad pharmacological effects, showing significant potential in cardiovascular diseases, cancer, metabolic syndromes, and neurodegenerative disorders.